nav emailalert searchbtn searchbox tablepage yinyongbenwen piczone journalimg journalInfo searchdiv qikanlogo popupnotification paper paperNew
2025, 07, v.27 6-10
益气升降方联合坐式八段锦治疗左心衰竭患者临床观察
基金项目(Foundation): 河北省中医药管理局科研计划项目(2019415)
邮箱(Email):
DOI: 10.13194/j.issn.1673-842X.2025.07.002
摘要:

目的 探讨益气升降方联合坐式八段锦治疗左心衰竭患者临床疗效。方法 选择于医院就诊的左心衰竭患者112例,采取简单化分组方法分为两组各56例,对照组患者给予坐式八段锦治疗,观察组在对照组基础上给予益气升降方治疗,观察两组患者治疗前后临床疗效,中医证候积分,6 min步行试验,心功能指标(左室射血分数,左心室收缩末期内径,N末端B型钠尿肽前体),心肺运动指标(二氧化碳通气当量斜率,峰值摄氧量,最大通气量),神经内分泌激素水平(促肾上腺皮质激素,醛固酮,血管紧张素Ⅱ)及明尼苏达州心衰患者生活质量问卷评分。结果 治疗后观察组总有效率为91.67%显著高于对照组75%(P<0.05);两组治疗后中医证候评分,左心室收缩末期内径、N末端B型钠尿肽前体、血清促肾上腺皮质激素、醛固酮、血管紧张素Ⅱ水平、二氧化碳通气当量斜率、明尼苏达州心衰患者生活质量问卷评分均较治疗前降低,且观察组低于对照组(P<0.05);两组治疗后左室射血分数、峰值摄氧量、最大通气量、6 min步行距离均较治疗前升高,且观察组高于对照组(P<0.05)。结论 益气升降方联合坐式八段锦治疗左心衰竭患者临床疗效显著。

Abstract:

Objective To investigate the clinical efficacy of Yiqi Shengjiang Decoction(益气升降方) combined with seated Baduanjin in treating patients with left heart failure. Methods A total of 112 left heart failure patients admitted to our hospital were divided into two groups(56 cases each)using a simplified grouping method. The control group received seated Baduanjin therapy,while the observation group received Yiqi Shengjiang Decoction in addition to the control group's treatment. Clinical efficacy,traditional Chinese medicine syndrome scores,6-minute walk test,cardiac function indices(left ventricular ejection fraction,left ventricular end-systolic diameter,N-terminal pro-B-type natriuretic peptide),cardiopulmonary exercise indices(ventilatory equivalent for carbon dioxide slope,peak oxygen uptake,maximum ventilation volume),neuroendocrine hormone levels(adrenocorticotropic hormone,aldosterone,angiotensin Ⅱ),and Minnesota living with heart failure questionnaire scores were evaluated before and after treatment. Results After treatment,the total effective rate in the observation group was 91.67% significantly higher than that in the control group 75%(P<0.05). Post-treatment TCM syndrome scores,left ventricular end-systolic diameter,N-terminal pro-B-type natriuretic peptide,serum adrenocorticotropic hormone,aldosterone,angiotensinⅡ levels,ventilatory equivalent for carbon dioxide slope,and Minnesota living with heart failure questionnaire scores decreased in both groups compared to pre-treatment levels,with lower values in the observation group(P<0.05). Left ventricular ejection fraction,peak oxygen uptake,maximum ventilation volume,and 6-minute walk test distance increased in both groups post-treatment,with higher values in the observation group(P<0.05). Conclusion The combination of Yiqi Shengjiang Decoction and seated Baduanjin demonstrates significant clinical efficacy in treating patients with left heart failure.

参考文献

[1] MOLLOY CD,LONG LD,MORDI IR,et al. Exercise-based cardiac rehabilitation for adults with heart failure-2023 Cochrane systematic review and meta-analysis[J]. Eur J Heart Fail,2023,25(12):2263-2273.

[2] YU T X,GAO M,SUN G Z,et al. Cardiac rehabilitation engagement and associated factors among heart failure patients:a cross-sectional study[J]. BMC Cardiovasc Disord,2023,23(1):447.

[3] RUAN T T,XU M Q,ZHU L Y,et al. Nurse-coordinated homebased cardiac rehabilitation for patients with heart failure:a scoping review[J]. Int J Nurs Sci,2023,10(4):435-445.

[4] ALHOTYE M,EVANS R,NG A,et al. Cardiac rehabilitation for heart failure and atrial fibrillation:a propensity-matched study[J]. Open Heart,2023,10(2):e002372.

[5] SIEGMUND LA,BENA JF,MORRISON SL. Cardiac rehabilitation facebook intervention:feasibility randomized controlled trial[J]. JMIR Cardio,2023,7:e46828.

[6]李佳,刘福明,方罡,等.抗心衰颗粒联合个体化有氧运动对慢性心力衰竭患者心肺功能的影响[J].实用心脑肺血管病杂志,2024,32(5):12-19.

[7]庞可心,韦红艳,刘艳梅,等.增免扶正方联合沙库巴曲缬沙坦片治疗慢性心力衰竭气血两虚证临床研究[J].河北中医,2024,46(4):552-557.

[8]何晶晶,宋娟,廖茂杉,等.温阳益气利水活血方剂联合沙库巴曲缬沙坦对慢性心力衰竭的疗效及对CD40L、Hcy水平的影响[J].四川中医,2024,42(4):123-127.

[9]谢继宏,陈艳俏.参附汤联合茯苓四逆汤治疗心阳亏虚型慢性心力衰竭患者的疗效及对其转化生长因子β1、Smad同源物3表达的影响[J].世界中西医结合杂志,2024,19(3):574-579,585.

[10]国家心血管病中心,国家心血管病专家委员会心力衰竭专业委员会,中国医师协会心力衰竭专业委员会,等.国家心力衰竭指南2023[J].中华心力衰竭和心肌病杂志,2023,7(4):215-311.

[11]中华中医药学会慢性心力衰竭中医诊疗指南项目组,毛静远.慢性心力衰竭中医诊疗指南(2022年)[J].中医杂志,2023,64(7):743-756.

[12]郑筱萸.中药新药临床研究指导原则:试行[M].北京:中国医药科技出版社,2002:69.

[13] RECTOR TS,COHN JN. Assessment of patient outcome with the Minnesota living with heart failure questionnaire:reliability and validity during a randomized,double-blind,placebocontrolled trial of pimobendan. pimobendan multicenter research group[J]. Am Heart J,1992,124(4):1017-1025.

[14]国家中医药管理局.中医病证诊断疗效标准[S].南京:南京中医药大学出版社,2002:77.

[15]龚帆影,杜玉颖,李佳,等.抗心衰方对慢性心力衰竭患者心功能及氧化应激功能的影响[J].南京中医药大学学报,2023,39(2):118-123.

[16]张倩,周彤,黄娟,等.坐式八段锦在急性心肌梗死PCI术后患者心脏康复中的应用效果[J].河北北方学院学报(自然科学版),2024,40(6):24-26.

[17]王霞.坐式八段锦对慢性心力衰竭伴衰弱患者心肺功能的影响研究[D].兰州:甘肃中医药大学,2024.

[18]俞阅彦,金丹丹,祝玉娟,等.坐式八段锦对急性前壁心肌梗死PCI术后患者心功能康复的影响[J].中国中医药科技,2022,29(6):988-991.

[19]胡晨晨,张梦雅,熊维,等.坐式八段锦联合运动康复治疗对急性冠状动脉综合征PCI术后患者运动耐力、血清心肌损伤标志物和生活质量的影响[J].现代生物医学进展,2023,23(9):1666-1670.

[20]王宇,杨帆,孙林.肾素-血管紧张素-醛固酮系统与心肌重塑关系研究进展[J].中国老年保健医学,2023,21(2):139-141,145.

[21]吴娇,仝芳超.黄芪的化学成分、药理作用及临床应用[J].滨州医学院学报,2024,47(1):68-75.

[22]杨乾方,王帆,潘立民,等.人参皂苷Rg3提取制备、化学结构及其药理作用研究进展[J].辽宁中医药大学学报,2023,25(12):196-202.

[23]林雪竹,李蔚群,关永霞,等.葶苈子化学成分及药理作用研究进展[J].中国现代中药,2022,24(3):550-558.

[24]陈雨萌,李倩,刘维海,等.丹参活性成分治疗心血管疾病的药理作用、临床应用及不良反应研究进展[J].药学研究,2023,42(12):1028-1034.

[25]赵雨芯,谢龙,李小芳,等.桔梗皂苷的药理作用研究进展[J].中药与临床,2022,13(2):94-98.

[26]莫家欣,陈汉坤,韩凌,等.东当归化学成分及药理活性研究进展[J].世界科学技术-中医药现代化,2023,25(9):3153-3163.

[27]李智,李汶泽,倪秀一,等.五味子提取物及其有效成分对心血管疾病的药理作用研究进展[J].药物评价研究,2023,46(8):1827-1832.

基本信息:

DOI:10.13194/j.issn.1673-842X.2025.07.002

中图分类号:R259

引用信息:

[1]李永新,高立威,王宇.益气升降方联合坐式八段锦治疗左心衰竭患者临床观察[J].辽宁中医药大学学报,2025,27(07):6-10.DOI:10.13194/j.issn.1673-842X.2025.07.002.

基金信息:

河北省中医药管理局科研计划项目(2019415)

检 索 高级检索

引用

GB/T 7714-2015 格式引文
MLA格式引文
APA格式引文